Therapeutic potential of ghrelin in cardiac diseases

References

• Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature402(6762), 656–660 (1999).
   PubMed Web of Science ®Google Scholar
• Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell132(3), 387–396 (2008).
   PubMed Web of Science ®Google Scholar
• Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab.12(3), 118–122 (2001).
   PubMed Web of Science ®Google Scholar
• Nakazato M, Murakami N, Date Y et al. A role for ghrelin in the central regulation of feeding. Nature409(6817), 194–198 (2001).
   PubMed Web of Science ®Google Scholar
• Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: ghrelin and the regulation of energy balance – a hypothalamic perspective. Endocrinology142(10), 4163–4169 (2001).
   PubMed Web of Science ®Google Scholar
• Date Y, Murakami N, Toshinai K et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology123(4), 1120–1128 (2002).
   PubMed Web of Science ®Google Scholar
• Kojima M, Kangawa K. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat. Clin. Prac.2(2), 80–88 (2006).
   Google Scholar
• Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res. Cardiol.98(6), 401–405 (2003).
   PubMed Web of Science ®Google Scholar
• Chang L, Zhao J, Li GZ et al. Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacol. Sin.25(9), 1131–1137 (2004).
   PubMed Web of Science ®Google Scholar
• Li L, Zhang LK, Pang YZ et al. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol. Sin.27(5), 527–535 (2006).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Uematsu M, Kojima M et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation104(17), 2034–2038 (2001).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Moriya J, Yasumura Y et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation110(24), 3674–3679 (2004).
   PubMed Web of Science ®Google Scholar
• Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr et al. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am. J. Physiol.287(6), H2885–H2890 (2004).
   Google Scholar
• Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Endocrinol. Metab.87(6), 2988 (2002).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation104(12), 1430–1435 (2001).
   PubMed Web of Science ®Google Scholar
• Soeki T, Kishimoto I, Schwenke DO et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am. J. Physiol.294(1), H426–H432 (2008).
   PubMed Web of Science ®Google Scholar
• Schwenke DO, Tokudome T, Kishimoto I et al. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology149(10), 5172–5176 (2008).
   PubMedGoogle Scholar
• Schwenke DO, Tokudome T, Shirai M et al. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. Endocrinology149(1), 237–244 (2008).
   PubMedGoogle Scholar
• Takaya K, Ariyasu H, Kanamoto N et al. Ghrelin strongly stimulates growth hormone release in humans. J. Endocrinol. Metab.85(12), 4908–4911 (2000).
   PubMed Web of Science ®Google Scholar
• Arvat E, Di Vito L, Broglio F et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest.23(8), 493–495 (2000).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Kojima M, Uematsu M et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol.280(5), R1483–R1487 (2001).
   PubMed Web of Science ®Google Scholar
• Janssen JA, Poldermans D, Hofland LJ et al. There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J. Endocrinol. Invest.27(7), 659–664 (2004).
   PubMed Web of Science ®Google Scholar
• Torsello A, Bresciani E, Rossoni G et al. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology144(5), 1787–1792 (2003).
   PubMed Web of Science ®Google Scholar
• Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature407(6806), 908–913 (2000).
   PubMed Web of Science ®Google Scholar
• Wren AM, Small CJ, Ward HL et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology141(11), 4325–4328 (2000).
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Kaga T et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology74(3), 143–147 (2001).
   PubMed Web of Science ®Google Scholar
• Toshinai K, Mondal MS, Nakazato M et al. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun.281(5), 1220–1225 (2001).
   PubMed Web of Science ®Google Scholar
• Katugampola SD, Pallikaros Z, Davenport AP. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br. J. Pharmacol.134(1), 143–149 (2001).
   PubMedGoogle Scholar
• Okumura H, Nagaya N, Enomoto M et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol.39(6), 779–783 (2002).
   PubMed Web of Science ®Google Scholar
• Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J. Pharmacol.136(8), 1146–1152 (2002).
   PubMed Web of Science ®Google Scholar
• Baldanzi G, Filigheddu N, Cutrupi S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell. Biol.159(6), 1029–1037 (2002).
   PubMed Web of Science ®Google Scholar
• Lin Y, Matsumura K, Fukuhara M et al. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension43(5), 977–982 (2004).
   PubMedGoogle Scholar
• Lawrence CB, Snape AC, Baudoin FM et al. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology143(1), 155–162 (2002).
   PubMed Web of Science ®Google Scholar
• Date Y, Murakami N, Kojima M et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun.275(2), 477–480 (2000).
   PubMed Web of Science ®Google Scholar
• Peino R, Baldelli R, Rodriguez-Garcia J et al. Ghrelin-induced growth hormone secretion in humans. Eur. J. Endocrinol.43(6), R11–R14 (2000).
   Google Scholar
• Muccioli G, Tschöp M, Papotti M et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol.440(2–3), 235–254 (2002).
   PubMed Web of Science ®Google Scholar
• Akamizu T, Kangawa K. Translational research on the clinical applications of ghrelin. Endocr. J.53(5), 585–591 (2006).
   PubMedGoogle Scholar
• Akamizu T, Iwakura H, Ariyasu H et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur. J. Endocrinol.158(4), 491–498 (2008).
   PubMedGoogle Scholar
• Akamizu T, Iwakura H, Ariyasu H et al. Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J. Am. Geriatr. Soc.56(12), 2363–2365 (2008).
   PubMedGoogle Scholar